Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Protocol of Korean JOint RegistrY for ALZheimer's Treatment and Diagnostics (JOY-ALZ).

Dementia and neurocognitive disorders·2026
Same author

Mechanisms and Impact of Cognitive Reserve in Normal Aging and Alzheimer's Disease.

Diagnostics (Basel, Switzerland)·2025
Same author

Association of qEEG TAR and TBR During Eyes-Open and Eyes-Closed with Plasma Oligomeric Amyloid-β Levels in an Aging Population.

Journal of clinical medicine·2025
Same author

Therapeutic Potential of Porcine Brain-Derived Peptide Mixture (PBDP) in Alzheimer's Disease: An Exploratory Study on Quantitative Electroencephalography (qEEG) Changes.

Neuropsychiatric disease and treatment·2025
Same author

Use of Amyloid Positron-Emission Tomography to Diagnose Alzheimer's Disease in Clinical Practice in South Korea: Expert Recommendations.

Journal of clinical neurology (Seoul, Korea)·2025
Same author

Difference between eyes-open and eyes-closed resting state quantitative electroencephalography (qEEG) for predicting cognitive impairment using deep learning.

Applied neuropsychology. Adult·2025

Related Experiment Video

Updated: Jul 30, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

288

Classification of Aβ State From Brain Amyloid PET Images Using Machine Learning Algorithm.

Chanda Simfukwe1, Reeree Lee2, Young Chul Youn1

  • 1Department of Neurology, Chung-Ang University College of Medicine, Seoul, Korea.

Dementia and Neurocognitive Disorders
|May 14, 2023
PubMed
Summary
This summary is machine-generated.

A convolutional neural network (CNN) model accurately classifies amyloid-beta (Aβ) deposition in brain PET scans, aiding Alzheimer's diagnosis. This AI tool offers objective and efficient screening for Aβ positive and negative patients.

Keywords:
AlgorithmsAmyloidPET ScanSupervised Machine Learning

More Related Videos

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.4K
Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

3.9K

Related Experiment Videos

Last Updated: Jul 30, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

288
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.4K
Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

3.9K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Analyzing brain amyloid positron emission tomography (PET) images for β-amyloid (Aβ) deposition in Alzheimer's disease is time-consuming and subject to interpreter variability.
  • Objective classification is needed to standardize the assessment of Aβ status from PET imaging.

Purpose of the Study:

  • To develop and evaluate a machine learning model using a convolutional neural network (CNN) for objective classification of Aβ positive and Aβ negative status from brain amyloid PET images.
  • To assess the clinical potential of the CNN model in screening amyloid PET scans.

Main Methods:

  • Utilized 7,344 brain amyloid PET images from 144 subjects, administered with 18F-florbetaben PET.
  • Classified images into Aβ positive and Aβ negative states based on physician-assessed brain amyloid plaque load scores (BAPL).
  • Trained a CNN algorithm on batches of 51 images per subject directory.

Main Results:

  • The CNN model achieved an average accuracy of 95.00±0.02% in classifying Aβ positivity and negativity on the test dataset.
  • Demonstrated high performance with a sensitivity of 96.00±0.02% and specificity of 94.00±0.02%.
  • Achieved an area under the curve (AUC) of 87.00±0.03 for binary classification.

Conclusions:

  • The developed CNN model shows significant potential for clinical application in screening amyloid PET images.
  • The model provides an objective and efficient method for assessing Aβ deposition, potentially improving Alzheimer's disease diagnosis.
  • Further clinical validation could establish this AI tool as a valuable aid for physicians in interpreting PET scans.